Genetic Insight into Putative Causes of Xanthelasma Palpebrarum: a Mendelian Randomization Study

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Apr 11

PMID 38601164

Authors

Wenting Hu

Yaozhong Liu

Cuihong Lian

Haocheng Lu

Affiliations

Soon will be listed here.

Abstract

Xanthelasma palpebrarum (XP) is the most common form of cutaneous xanthoma, with a prevalence of 1.1%~4.4% in the population. However, the cause of XP remains largely unknown. In the present study, we used Mendelian randomization to assess the genetic association between plasma lipids, metabolic traits, and circulating protein with XP, leveraging summary statistics from large genome-wide association studies (GWAS). Genetically predicted plasma cholesterol and LDL-C, but not HDL-C or triglyceride, were significantly associated with XP. Metabolic traits, including BMI, fasting glucose, type 2 diabetes, systolic and diastolic blood pressure, were not significantly associated with XP. Furthermore, we found genetically predicted 12 circulating proteins were associated with XP, including FN1, NTM, FCN2, GOLM1, ICAM5, PDE5A, C5, CLEC11A, CXCL1, CCL2, CCL11, CCL13. In conclusion, this study identified plasma cholesterol, LDL-C, and 12 circulating proteins to be putative causal factors for XP, highlighting the role of plasma cholesterol and inflammatory response in XP development.

References

Zhimin W, Hui W, Fengtao J, Wenjuan S, Yongrong L . Clinical and serum lipid profiles and LDLR genetic analysis of xanthelasma palpebrarum with nonfamilial hypercholesterolemia. J Cosmet Dermatol. 2020; 19(11):3096-3099. DOI: 10.1111/jocd.13366. View

Christoffersen M, Frikke-Schmidt R, Schnohr P, Jensen G, Nordestgaard B, Tybjaerg-Hansen A . Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study. BMJ. 2011; 343:d5497. PMC: 3174271. DOI: 10.1136/bmj.d5497. View

Kavoussi H, Ebrahimi A, Rezaei M, Ramezani M, Najafi B, Kavoussi R . Serum lipid profile and clinical characteristics of patients with xanthelasma palpebrarum. An Bras Dermatol. 2016; 91(4):468-71. PMC: 4999105. DOI: 10.1590/abd1806-4841.20164607. View

Mendelson B, MASSON J . Xanthelasma: follow-up on results after surgical excision. Plast Reconstr Surg. 1976; 58(5):535-8. View

Struyk A, Canoll P, Wolfgang M, Rosen C, DEustachio P, Salzer J . Cloning of neurotrimin defines a new subfamily of differentially expressed neural cell adhesion molecules. J Neurosci. 1995; 15(3 Pt 2):2141-56. PMC: 6578143. View

McDonough C, Warren H, Jack J, Motsinger-Reif A, Armstrong N, Bis J . Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies. Clin Pharmacol Ther. 2021; 110(3):723-732. PMC: 8672325. DOI: 10.1002/cpt.2355. View

Hu Y, Zhang Y, Ni C, Chen C, Rao S, Yin H . Human umbilical cord mesenchymal stromal cells-derived extracellular vesicles exert potent bone protective effects by CLEC11A-mediated regulation of bone metabolism. Theranostics. 2020; 10(5):2293-2308. PMC: 7019162. DOI: 10.7150/thno.39238. View

Li L, Dai F, Wang L, Sun Y, Mei L, Ran Y . CCL13 and human diseases. Front Immunol. 2023; 14:1176639. PMC: 10154514. DOI: 10.3389/fimmu.2023.1176639. View

Kim Y, Oh J, Lee K, Yoon S . Clinical association between serum cholesterol level and the size of xanthelasma palpebrarum. Arch Craniofac Surg. 2022; 23(2):71-76. PMC: 9081426. DOI: 10.7181/acfs.2022.00185. View

10.

Chen G, Deutsch G, Schulert G, Zheng H, Jang S, Trapnell B . Identification of Distinct Inflammatory Programs and Biomarkers in Systemic Juvenile Idiopathic Arthritis and Related Lung Disease by Serum Proteome Analysis. Arthritis Rheumatol. 2022; 74(7):1271-1283. PMC: 9246966. DOI: 10.1002/art.42099. View

11.

Kousathanas A, Pairo-Castineira E, Rawlik K, Stuckey A, Odhams C, Walker S . Whole-genome sequencing reveals host factors underlying critical COVID-19. Nature. 2022; 607(7917):97-103. PMC: 9259496. DOI: 10.1038/s41586-022-04576-6. View

12.

Chang H, Sung C, Lin M . Serum lipids and risk of atherosclerosis in xanthelasma palpebrarum: A systematic review and meta-analysis. J Am Acad Dermatol. 2019; 82(3):596-605. DOI: 10.1016/j.jaad.2019.08.082. View

13.

Ferrando J, Bombi J . Ultrastructural aspects of normolipidemic xanthomatosis. Arch Dermatol Res. 1979; 266(2):143-59. DOI: 10.1007/BF00694624. View

14.

Cao T, Quinn P, Sandhu J, Voors A, Lang C, Parry H . Identification of novel biomarkers in plasma for prediction of treatment response in patients with heart failure. Lancet. 2015; 385 Suppl 1:S26. DOI: 10.1016/S0140-6736(15)60341-5. View

15.

Zhao J, Stacey D, Eriksson N, Macdonald-Dunlop E, Hedman A, Kalnapenkis A . Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets. Nat Immunol. 2023; 24(9):1540-1551. PMC: 10457199. DOI: 10.1038/s41590-023-01588-w. View

16.

Pankov R, Yamada K . Fibronectin at a glance. J Cell Sci. 2002; 115(Pt 20):3861-3. DOI: 10.1242/jcs.00059. View

17.

Singh S, Anshita D, Ravichandiran V . MCP-1: Function, regulation, and involvement in disease. Int Immunopharmacol. 2021; 101(Pt B):107598. PMC: 8135227. DOI: 10.1016/j.intimp.2021.107598. View

18.

Martin A, Allen C, Pang J, Watts G . Detecting familial hypercholesterolemia: The Jack and the Beanstalk principle. J Clin Lipidol. 2017; 11(2):575-578. DOI: 10.1016/j.jacl.2017.02.003. View

19.

Kalaoja M, Corbin L, Tan V, Ahola-Olli A, Havulinna A, Santalahti K . The Role of Inflammatory Cytokines as Intermediates in the Pathway from Increased Adiposity to Disease. Obesity (Silver Spring). 2021; 29(2):428-437. PMC: 8614117. DOI: 10.1002/oby.23060. View

20.

Khode S, Tan S, Tan E, Uppal S . Xanthelasma Palpebrarum: More than Meets the Eye. Indian J Otolaryngol Head Neck Surg. 2019; 71(Suppl 1):439-446. PMC: 6848656. DOI: 10.1007/s12070-018-1345-0. View